Stock Information
Recursion Pharmaceuticals Inc (RXRX)
Ticker Symbol: RXRX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,619.20 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -1.4848
Revenue (TTM): $0.14 M
Dividend Yield: N/A%
ROE: -63.98%
Latest News
-
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
Fri, May 8, 2026 1:25 PM
-
Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull Back
Thu, May 7, 2026 1:04 PM
-
Needham Reiterates Buy on Recursion Pharmaceuticals, Maintains $8 Price Target
Thu, May 7, 2026 8:03 AM
-
Recursion Pharmaceuticals, Inc. (RXRX) Q1 2026 Earnings Call Transcript
Wed, May 6, 2026 7:51 PM
-
Transcript : Recursion Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 06, 2026
Wed, May 6, 2026 7:40 PM
-
Earnings Scheduled For May 6, 2026
Wed, May 6, 2026 5:03 PM
-
Recursion Pharmaceuticals (RXRX) Q1 2026 Results: Revenue Miss Overshadows Narrower Net Loss
Wed, May 6, 2026 11:21 AM
-
Recursion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Wed, May 6, 2026 9:37 AM
-
Recursion Pharmaceuticals: Q1 Earnings Snapshot
Wed, May 6, 2026 6:37 AM
-
Recursion Pharmaceuticals Q1 EPS $(0.22) Beats $(0.27) Estimate, Sales $6.472M Miss $15.777M Estimate
Wed, May 6, 2026 6:31 AM
Key Financials
Financial data not available
